This announcement is a separate document:
重药控股：北京中伦（成都）律师事务所关于重药控股股份有限公司终止2020年限制性股票激励计划暨回购注销限制性股票实施情况的法律意见书
Heavy Pharmaceutical Holdings: Legal opinion of Beijing Zhonglun (Chengdu) Law Firm on the termination of the 2020 Restricted Stock Incentive Plan and the implementation of the repurchase and cancellation of restricted stocks by Heavy Pharmaceutical Holdin
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.